Kennedy Halts FDA Tanning‑Bed Ban for Minors, Cites Personal Choice

Context The FDA had drafted a rule to prohibit anyone under 18 from using sunlamp products and to mandate explicit cancer‑risk acknowledgments before use. Public health experts warned that ultraviolet radiation from tanning beds significantly raises the likelihood of melanoma, especially when exposure begins in adolescence. Kennedy’s withdrawal of the proposal aligns with a broader pattern of his health agenda that questions regulatory interventions, including his past calls to reassess vaccine safety and promote raw‑milk access.

Key Facts Kennedy stated the decision rested on “personal choice” and parental decision‑making, a direct quote from his statement. He halted the FDA-backed proposal that would have banned minors from tanning beds and required warning labels. Separately, Kennedy has faced criticism for questioning whether vaccines have been sufficiently tested and for urging a re‑examination of long‑standing vaccine safety conclusions.

Scientific evidence shows a clear association between early tanning‑bed use and melanoma. A 2019 meta‑analysis of 27 observational studies encompassing more than 14,000 melanoma cases reported a 1.6‑fold increased risk for those who first used tanning beds before age 35. A large prospective cohort study of over 400,000 European women found that each additional tanning‑bed session per year raised melanoma incidence by approximately 1.8 %. These designs establish correlation; researchers note that confounding factors such as skin phenotype and sun‑exposure habits are adjusted for, strengthening the inference that UV exposure from tanning beds contributes causally to melanoma risk.

What It Means By prioritizing personal choice over precautionary limits, the policy shift may increase melanoma risk among teenagers, a group already vulnerable to UV‑induced DNA damage. Public health officials warn that weakening such safeguards could erode decades of progress in cancer prevention. Moving forward, watch for any new FDA guidance on tanning‑bed regulation, potential legislative responses at the state level, and whether Kennedy’s office revisits other youth‑health proposals such as raw‑milk access or vaccine‑safety reviews.